Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat

Thrombosis and Haemostasis

Volumn 81, Issue 6, 1999, Pages 957-960

  Herault J P ^a   Dol, F ^a   Gaich, C ^a   Bernat, A ^a   Herbert, J M ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; HEPARIN; THROMBIN; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOTTING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VEIN THROMBOSIS;

EID: 0033058683     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614606     Document Type: Article

References (15)

1. Walsh PM, Schmaler AH. Platelet-coagulant protein interactions. In: Hemostasis & Thrombosis: Basic principles and clinical practice, 3rd. Colman RW, Hirsh J, Marder VJ, Salzman EW, ed. Philadelphia: JB Lippincott Co. 1994; 629-51.
2. Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol 1987; 18: 111-32.
3. Bevers EM, Comfurius P, Van Rijn JLML, Hemker C, Zwaal RFA. Generation of prothrombin-converting activity and the exposure of phosphatidyl serine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-36.
4. Bevers EM, Comfurius P, Zwaal RFA. Mechanismus involved in platelets procoagulant response. In mechanism of platelet activation and control. Authi KS et al. (eds). New York: Plenum Publishing Corp 195-207.
5. Beguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost 1989; 61: 25-9.
6. Reverter JC, Beguin S, Kessels R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. J Clin Invest 1996; 98: 863-74.
7. Hérault JP, Peyrou V, Savi P, Bernat B, Herbert JM. Effect of SR121566A, a potent GpIIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Thromb Haemost 1998; 79: 383-8.
8. Herbert JM, Frehel D, Bernat A, Badorc A, Savi P, Delebassée D, Kieffer G, Defreyn G, Maffrand JP. Clopidogrel hydrogenosulfate. Drugs of the Future 1993; 18: 107-12.
9. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). The Lancet 1996; 348: 1329-39.
10. Bernat A, Vallée E, Maffrand JP, Gordon JL. The role of platelets and ADP in experimental thrombosis induced by venous stasis in the rat. Thromb Res 1988; 52: 65-70.
11. Herbert JM, Bernat A, Maffrand JP. Importance of platelets in experimental venous thrombosis in the rat. Blood 1992; 80: 2281-6.
12. Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
13. Peyrou V, Lormeau JC, Hérault JP, Boneu B, Herbert JM. Long term persistence of low molecular weight material with anti-factor Xa activity contributes to the anticoagulant and antithrombotic effects after subcutaneous injection of CY 216 in the rabbit. Blood Coag Fibrinol 1997; 8: 175-84.
14. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous reigstration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
15. Walenga JM, Petitou M, Lormeau JC, Samama M, Fareed J, Choay J. Antithrombotic activity of a synthetic heparin pentaspirinccharide in a rabbit stasis thrombosis model using different thrombogenic challenges. Thromb Res 1987; 46: 187-98.